{"id":"W4205852291","doi":"10.1002/jha2.359","title":"Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group","year":2022,"lang":"en","type":"article","venue":"eJHaem","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Stem Cell Network","funders":"","keywords":"Daratumumab; Lenalidomide; Medicine; Bortezomib; Multiple myeloma; Internal medicine; Dexamethasone; Oncology; Neutropenia; Carfilzomib; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007595905,0.0005290236,0.0008719027,0.0002374576,0.0006798375,0.00007416709,0.000357353,0.0001396859,0.0006466001],"category_scores_gemma":[0.001421077,0.000334202,0.000143136,0.0006984051,0.000319609,0.0002147637,0.0005028975,0.001076364,0.00003562181],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005524945,"about_ca_system_score_gemma":0.0003276043,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003650186,"about_ca_topic_score_gemma":0.007591714,"domain_scores_codex":[0.9953925,0.0005634747,0.0008130772,0.001057243,0.001316324,0.0008573533],"domain_scores_gemma":[0.9959265,0.00186379,0.0003709121,0.001221996,0.0001712891,0.0004455298],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02630866,0.002149511,0.9405929,0.0000464152,0.0005152994,0.007617052,0.00138338,0.00001548838,0.0008470218,0.00001288592,0.003503778,0.01700756],"study_design_scores_gemma":[0.04709154,0.003446726,0.9254222,0.0001570579,0.0001471614,0.0003766661,0.001477145,0.001222112,0.0006740832,0.00003468842,0.01952978,0.0004208524],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994462,0.0008167095,0.00003474679,0.0009140233,0.0002488094,0.002487103,0.0003200309,0.0001349137,0.000581703],"genre_scores_gemma":[0.9935288,0.00006406438,0.001876854,0.0004553869,0.0001416203,0.0007892123,0.00138568,0.0001157301,0.001642655],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02078288,"threshold_uncertainty_score":0.999911,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02396165785600094,"score_gpt":0.2675837768400287,"score_spread":0.2436221189840277,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}